TB-1677 · REV A · Technical newsheet

Sensors & InstrumentationDevice profile

Gates Foundation Puts $11.6 Million Into On-Device AI Ultrasound

The Gates Foundation granted Exo $11.6 million to build a handheld ultrasound system with on-device AI, targeting frontline workers in low- and middle-income countries without reliable connectivity.

By Grace Kim3 min read620 words

Features

  • The Gates Foundation granted Exo $11.6 million for next-generation handheld ultrasound development.
  • The device runs AI on-device, requiring no continuous internet connection.
  • Target users are frontline healthcare workers in low- and middle-income countries without specialized ultrasound training.
  • CEO Sandeep Akkaraju said the funding advances a platform for communities with limited imaging and specialist access.
  • The platform also covers OEM-integrated products, procedure guidance, patient monitoring and therapeutic uses.
Exo Secures $11.6 Million Gates Foundation Grant to Expand AI-Powered Ultrasound Access in Developing Countries
Device photoExo Secures $11.6 Million Gates Foundation Grant to Expand AI-Powered Ultrasound Access in Developing Countries — shatishira / pixabay

The Gates Foundation has granted $11.6 million to Exo, a medical imaging company building artificial-intelligence-powered ultrasound hardware, to develop an affordable handheld ultrasound system for frontline health workers in low- and middle-income countries.

The grant funds a next-generation device that lets healthcare workers without specialized ultrasound training acquire diagnostic images and perform risk screening. Exo, based in the U.S. and publishing details at exo.inc, frames the program as an answer to four barriers that have kept imaging out of underserved clinics: high equipment costs, shortages of trained specialists, complex imaging procedures and unreliable internet connectivity.

Where does the AI run?

On the device, not in the cloud. Exo pairs proprietary piezoelectric silicon imaging hardware with AI that executes directly on the handheld unit, providing real-time guidance during both image acquisition and interpretation. The architecture needs no continuous internet connection, which separates it from cloud-dependent diagnostic systems that fail where rural connectivity is weak.

That design choice defines the target environment. A clinic in a resource-constrained region cannot assume bandwidth, steady power-adjacent infrastructure, or a sonographer on staff. On-device inference shifts the technical burden from the site to the silicon, letting a worker with minimal ultrasound training capture a usable image and support a clinical risk assessment on the spot. The takeaway: the computational location is the product decision that makes this deployable.

What did Exo say?

CEO Sandeep Akkaraju tied the funding directly to the silicon-plus-AI combination. "By combining silicon imaging with on-device AI, we're working to make ultrasound more affordable and easier for frontline healthcare workers to use," Akkaraju said in the announcement.

He also framed the grant as continued, not first-time, backing. "This funding will help us advance a platform designed for communities where access to imaging and specialist expertise is limited. We're grateful to the Gates Foundation for its continued support," he said.

The word "continued" signals that the foundation has evaluated Exo's platform before — a relevant data point for anyone tracking which ultrasound architectures major global-health funders consider viable at scale.

What does the platform cover?

The grant-funded work builds on the same silicon imaging and AI architecture Exo already sells, with emphasis on lower-resource settings. The company's technology stack covers several distinct outputs:

  • A compact handheld ultrasound device for multiple medical applications
  • Handheld imaging products integrated by original equipment manufacturers
  • Applications beyond diagnostics: procedure guidance, patient monitoring and emerging therapeutic uses

By integrating AI-assisted guidance and interpretation, Exo aims to strip out the technical complexity traditionally attached to ultrasound exams. Workers without extensive training should be able to produce diagnostic-quality images rather than blurred, uninterpretable frames that require a specialist to salvage. The practical goal is simple: move imaging from the radiology department to the point of first contact.

What remains unmeasured?

The announcement states aims, not measured results. Exo has not yet published accuracy figures, image-quality benchmarks, or clinical validation data for the grant-funded device, and no delivery date appears in the material. Readers evaluating the claim that untrained users can acquire diagnostic-grade images should treat that as a design target until independent field data from low-resource settings arrives.

The $11.6 million covers development work, and the company positions it as additional support for an ongoing expansion of ultrasound availability where conventional equipment and trained specialists are scarce.

The question the grant raises for the test and measurement community: will on-device AI guidance prove reliable enough, under field conditions and without a trained operator in the loop, to meet the diagnostic bar that regulators and global health programs demand before deployment at scale?

via citybiz.co (Source)

Filed under

  • medical-imaging
  • ultrasound
  • on-device-ai
  • edge-computing
  • global-health
Share this article:

More from Grace Kim

Grace Kim

Show full bio

Correspondent covering companies, deals and strategy in Instruments, test and measurement at Testbench Report.

116 articles

Application notes

« Previous article